<DOC>
	<DOCNO>NCT01641731</DOCNO>
	<brief_summary>Induction oral tolerance child allergic cow 's milk proteins risk-free . The analysis factor may influence outcome utmost importance . The aim study analyse efficacy safety induction phase oral tolerance induction accord specific IgE level , well adverse event maintenance phase . Patients allergic cow 's milk include oral tolerance induction protocol . Patients group accord specific IgE level serum ( ImmunoCAP ) group I ( sIgE &lt; 3.5 kU/L ) , II ( sIgE 3.5-17 kU/L ) III ( &gt; 17-50kU/L ) . Allergic child similar characteristic include control group . Visits establish 1 , 6 12 month induction phase . Serum specific IgE level cow 's milk protein determine inclusion , 6 12 month visit induction phase .</brief_summary>
	<brief_title>Specific Oral Tolerance Induction Children Allergic Cow 's Milk Proteins</brief_title>
	<detailed_description>Children allergic cow 's milk protein ( CMA ) include . They diagnose CMA first year life attend periodic follow-up visit Allergy Clinic Hospital La Paz ( Madrid , Spain ) . Clinical data personal history asthma , allergy food positive reaction upon cow 's milk ingestion along evolution initial diagnosis record . Prior inclusion SOTI protocol , determination serum specific IgE cow 's milk ( CM ) , ALA , BLG casein ( ImmunoCAP , Phadia , Uppsala , Sweden ) perform current clinical status confirm oral food challenge ( OFC ) cow 's milk . An open OFC CM ( 3 g protein per 100 mL ) perform follow modify protocol accord level allergic sensitisation . Group I start dose 2 mL , group II III start dose 0.005 mL . In protocols dos double objective clinical reactivity achieve . Determination serum specific IgE cow 's milk proteins perform follow-up 6 12 month visit . In order evaluate influence level sensitisation result SOTI , patient classify three group accord level sIgE CM and/or protein : group I ( 0.35-3.5 kU/L , CAP Class I II ) ; group II ( &gt; 3.5-17 kU/L , CAP Class III ) ; group III ( &gt; 17-50kU/L , CAP Class IV ) . The high sIgE level CM proteins determine group inclusion . A control group cow 's milk allergic child , similar level sIgE , include order evaluate natural evolution tolerance CMA . They follow one year , , clinical reactivity OFC confirm . These control patient select among , initial OFC , refuse undergo SOTI . Specific Oral Tolerance Induction : The initial dose SOTI previous dose elicit symptom OFC . Group I dose upped weekly hospital setting , patient maintain dose twice daily home . Groups II III also start previous dose elicit symptom OFC , receive incremental dos daily hospital set reach dose 1 mL . Achieving intake 200 mL milk ( 6 g protein ) twice day , usual amount patient age , consider complete tolerance . Reactions occur induction phase hospital treat accord severity symptom . If patient present mild non-objective symptom , dose repeat . If reaction objective limit local symptom , previous dose give resolution symptom . If reaction generalise , involve two organ system , SOTI continue dose two dos previous one elicit symptom . If reaction involve three organ system , next dose administer reduced three step dosage protocol . Written instruction give parent regard treat possible adverse reaction home . After induction phase , patient continue consume 200 mL milk twice daily dairy product allow freely . In maintenance phase , follow-up visit schedule one month , six month one year finish induction phase . Data tolerance cow 's milk dairy product record . Adverse event upon ingestion also record .</detailed_description>
	<mesh_term>Milk Hypersensitivity</mesh_term>
	<criteria>Patients diagnose cow 's milk allergy meeting follow criterion : Immediatetype clinical manifestation , skin ( urticaria , angioedema and/or erythema ) , digestive ( acute vomit and/or diarrhea ) respiratory ( bronchospasm and/or rhinitis ) involvement first two hour cow 's milk ingestion . Skin test reading â‰¥ 3 mm specific IgE titer &gt; 0.35 kU/l whole cow 's milk someone isolate CMPs ( casein , alphalactalbumin , betalactoglobulin ) Age 4 year old old Specific IgE ( measure ImmunoCAP ) low 50 KU/L cow 's milk proteins Positive oral food challenge dose high 2 mL Written inform consent sign parent legal representative Age young 4 y.o . Specific IgE high 50 kU/L Patients oral food challenge contraindicate , positive accidental reaction moderate severe symptom previous 12 month prior inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>cow 's milk protein allergy</keyword>
	<keyword>oral tolerance induction</keyword>
</DOC>